Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Talbot JA, Chomyc S, Davison E, Singer J, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG. Shafran SD, et al. Among authors: phillips p. Clin Infect Dis. 1998 Dec;27(6):1401-5. doi: 10.1086/515022. Clin Infect Dis. 1998. PMID: 9868650 Clinical Trial.
Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
Shafran SD, Mashinter LD, Phillips P, Lalonde RG, Gill MJ, Walmsley SL, Toma E, Conway B, Fong IW, Rachlis AR, Williams KE, Garber GE, Schlech WF, Smaill F, Pradier C. Shafran SD, et al. Among authors: phillips p. Ann Intern Med. 2002 Nov 5;137(9):734-7. doi: 10.7326/0003-4819-137-9-200211050-00008. Ann Intern Med. 2002. PMID: 12416943
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. Shafran SD, et al. Among authors: phillips p. N Engl J Med. 1996 Aug 8;335(6):377-83. doi: 10.1056/NEJM199608083350602. N Engl J Med. 1996. PMID: 8676931 Free article. Clinical Trial.
Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: a multivariate analysis. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Singer J, Zarowny DP, Deschênes J, Phillips P, Turgeon F, Aoki FY, Toma E, Miller M, Duperval R, Lemieux C, Schlech WF 3rd. Shafran SD, et al. Among authors: phillips p. J Infect Dis. 1998 Jan;177(1):252-5. doi: 10.1086/517366. J Infect Dis. 1998. PMID: 9419201 Clinical Trial.
Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study Group.
Singer J, Thorne A, Phillips P, Rachlis AR, Miller M, Gill MJ, Smaill FM, Schlech WF 3rd, Senay H, Shafran SD. Singer J, et al. Among authors: phillips p. AIDS. 1999 Apr 1;13(5):575-82. doi: 10.1097/00002030-199904010-00006. AIDS. 1999. PMID: 10203382 Clinical Trial.
A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome.
Austin J, Singhal N, Voigt R, Smaill F, Gill MJ, Walmsley S, Salit I, Gilmour J, Schlech WF 3rd, Choudhri S, Rachlis A, Cohen J, Trottier S, Toma E, Phillips P, Ford PM, Woods R, Singer J, Zarowny DP, Cameron DW; CTN 091/CRIT Cartenoids Study Group. Austin J, et al. Among authors: phillips p. Eur J Clin Nutr. 2006 Nov;60(11):1266-76. doi: 10.1038/sj.ejcn.1602447. Epub 2006 May 24. Eur J Clin Nutr. 2006. PMID: 16721396 Clinical Trial.
2,731 results